Two patients received only cytokines prior to tumour sampling, while others were pretreated with VEGF‐targeted therapy (n = 36), mTOR inhibitors (n = 15) or immune checkpoint inhibitors (n = 7). This evidence concerns the gene MTOR and neoplasm.